Triax Report issue

Contributed to NME Academic/Hospital Phase 2
Status: Acquired by PreCision Dermatology (2012) → now Bausch Health Companies (2014)

Organization Overview

First Clinical Trial
2007
NCT00556491
First Marketed Drug
1971
minocycline (minocin)
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Triax Pharmaceuticals | TRIAX PHARMS

Active Ingredients

Marketed Drugs (1)

minocycline (minocin) (1971 NDA)

Drugs in Phase 2 Trials (2)

edetic acid (1 trial)

minocycline (minocin) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2